We are currently recruiting adults for the Allevia 2 Study evaluating an investigational medication to help reduce tics associated with Tourette Syndrome.
Study care, including study medication, is provided at no cost to participants and is overseen by experienced medical professionals. Reimbursement may be provided for study-related travel costs.
You may qualify for the study if you:
- Are 18 years of age or older
- Have been diagnosed with Tourette Syndrome
There is no cost to take part in the Allevia 2 Study.
Sign Up
What happens if I fill out the pre-screening questionnaire?
If you pass the initial study screen, we will match you to a study location in your area that is looking for participants with Tourette Syndrome or notify you as soon as one becomes available. If there is not a current study center in your area, a Patient Engagement Specialist can also reach out to you in the future to share information about new study opportunities you may qualify for.
Keep in mind that participation is entirely your decision.
About Tourette Syndrome (TS)
Tourette Syndrome (TS) is a movement disorder involving multiple tics (sudden, recurring movement or sound) that vary in severity.1 There is no specific test that can diagnose someone with TS. A diagnosis is based on signs and symptoms, including a history of:
- Both motor and vocal tics beginning before age 18
- Tics that occur a few times a day, nearly every day or occasionally, for over a year
- Tics that are not caused by medication, substances, or other medical condition2
Currently, there is no cure for Tourette Syndrome, and treatment is difficult due to the condition’s complexity—there is no known cause at this time.1 Treatment options include: oral medications like aripiprazole or haloperidol, and psychotherapy (cognitive behavioral therapy).
The need to develop an effective treatment for the clinical management of Tourette Syndrome is crucial as tics have a profound impact on a TS patient’s quality of life. Depression and anxiety symptoms are extremely common in people with TS.3
Frequently Asked Questions
What is a clinical research study?
A clinical research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved FDA and prescribed to patients.
Why are clinical research studies important?
A clinical research study is the process by which new and innovative medications, interventions and treatments are approved and brought to market to offer medical advances and new treatment options. Even over-the-counter medications, such as NSAIDs you may have used to counteract a headache, have gone through the clinical research study process before it was available at your local pharmacy.
Will I be reimbursed?
Those who qualify to take part in the Allevia 2 Study may be reimbursed for study-related travel. Please discuss this with the study team when they contact you.
What else do I need to consider?
The research team will be able to explain more about what the Allevia 2 Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study site?
We will match you to a study site within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decide you no longer want your information stored, you can opt out and we will delete your details.
About the Allevia 2 Study
The Allevia 2 Study is looking to enroll adults (18 years and older) with Tourette Syndrome (TS) at study sites across the United States and Europe. The study will be about 5 months in duration and will involve a 12-week treatment period plus a follow-up period. During treatment, you may receive study medication designed to reduce tics associated with Tourette Syndrome.
During this time, a dedicated medical team will provide participants with all study-related care at no cost. Reimbursement may be provided for study-related travel.
Who can participate?
You may be able to join the study if you:
- Are 18 years of age or older
- Have been diagnosed with Tourette Syndrome